Clinical Trial Update: A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating tolerability and pharmacokinetics of single and multiple high-dose regimens of the epilepsy drug candidate BIA 2-093 in healthy volunte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BIA 2-093

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-30